ST PharmLtd Balance Sheet Health
Financial Health criteria checks 4/6
ST PharmLtd has a total shareholder equity of ₩428.2B and total debt of ₩156.1B, which brings its debt-to-equity ratio to 36.5%. Its total assets and total liabilities are ₩666.2B and ₩238.0B respectively. ST PharmLtd's EBIT is ₩27.0B making its interest coverage ratio 7.4. It has cash and short-term investments of ₩110.3B.
Key information
36.5%
Debt to equity ratio
₩156.10b
Debt
| Interest coverage ratio | 7.4x |
| Cash | ₩110.31b |
| Equity | ₩428.24b |
| Total liabilities | ₩237.97b |
| Total assets | ₩666.22b |
Recent financial health updates
Recent updates
ST Pharm Co.,Ltd.'s (KOSDAQ:237690) Shares Climb 29% But Its Business Is Yet to Catch Up
Aug 30
Is Now The Time To Put ST PharmLtd (KOSDAQ:237690) On Your Watchlist?
Aug 17Is ST Pharm Co.,Ltd. (KOSDAQ:237690) Trading At A 41% Discount?
May 09Why ST PharmLtd's (KOSDAQ:237690) Earnings Are Better Than They Seem
Mar 22ST Pharm Co.,Ltd. (KOSDAQ:237690) Stock Rockets 54% As Investors Are Less Pessimistic Than Expected
Mar 18Investors Who Bought ST PharmLtd (KOSDAQ:237690) Shares A Year Ago Are Now Up 221%
Mar 16Calculating The Fair Value Of ST Pharm Co.,Ltd. (KOSDAQ:237690)
Jan 22What Type Of Shareholders Own The Most Number of ST Pharm Co.,Ltd. (KOSDAQ:237690) Shares?
Dec 23Health Check: How Prudently Does ST PharmLtd (KOSDAQ:237690) Use Debt?
Nov 26
Financial Position Analysis
Short Term Liabilities: A237690's short term assets (₩324.4B) exceed its short term liabilities (₩76.3B).
Long Term Liabilities: A237690's short term assets (₩324.4B) exceed its long term liabilities (₩161.7B).
Debt to Equity History and Analysis
Debt Level: A237690's net debt to equity ratio (10.7%) is considered satisfactory.
Reducing Debt: A237690's debt to equity ratio has increased from 0.04% to 36.5% over the past 5 years.
Debt Coverage: A237690's debt is not well covered by operating cash flow (14.4%).
Interest Coverage: A237690's interest payments on its debt are well covered by EBIT (7.4x coverage).